Displaying 433 - 444 of 452
General Hepatology
7

Norgine: Preventing a domino effect in the management of hepatic encephalopathy - The International Liver Congress™ 2019

View
General Hepatology
7

Norgine: Preventing a domino effect in the management of hepatic encephalopathy - The International Liver Congress™ 2019

View
General Hepatology
7

Norgine: Preventing a domino effect in the management of hepatic encephalopathy - The International Liver Congress™ 2019

View
General Hepatology
7

Norgine: Preventing a domino effect in the management of hepatic encephalopathy - The International Liver Congress™ 2019

View
General Hepatology
7

Norgine: Preventing a domino effect in the management of hepatic encephalopathy - The International Liver Congress™ 2019

View
General Hepatology
7

Norgine: Preventing a domino effect in the management of hepatic encephalopathy - The International Liver Congress™ 2019

View
General Hepatology
7

Norgine: Preventing a domino effect in the management of hepatic encephalopathy - The International Liver Congress™ 2019

View
Cirrhosis & Complications
4

Grifols: Albumin: a disease-modifying agent in decompensated cirrhosis - Digital ILC 2020

View
Cirrhosis & Complications
4

Grifols: Albumin: a disease-modifying agent in decompensated cirrhosis - Digital ILC 2020

View
Cirrhosis & Complications
4

Grifols: Albumin: a disease-modifying agent in decompensated cirrhosis - Digital ILC 2020

View
Cirrhosis & Complications
4

Grifols: Albumin: a disease-modifying agent in decompensated cirrhosis - Digital ILC 2020

View
Cirrhosis & Complications
6

Grifols: Extending the treatment paradigm for cirrhosis: long-term albumin administration and beyond - The International Liver Congress™ 2019

View
Displaying 433 - 444 of 452